PortViewPortView
IQVIA logo

IQVIA (IQV) Stock Analysis

NYSEHealth CareLife Sciences Tools

$262.35+1.55%
1-year price historyRange $156.66 – $263.68
52-week range$262.35
$154.50$265.25

What IQVIA does

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Key metrics

Market cap
$43.18B
P/E (TTM)
21.63
EPS (TTM)
$12.13
Beta
1.18
Dividend yield
0.00%
Revenue / share
$101.57
50-day avg
$224.93
200-day avg
$201.17
52-week high
$265.25
52-week low
$154.50
CEO
Ari Bousbib

ETFs linked to IQV

Broad-market and Health Care sector ETFs an investor holding IQVIA is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IQV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IQV in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for IQVIA?
IQVIA trades under the ticker IQV on NYSE.
Which exchange is IQV listed on?
IQV is listed on NYSE.
What sector does IQVIA operate in?
IQVIA is classified in the Health Care sector (Life Sciences Tools industry).
How can PortView help analyze IQV in a portfolio?
PortView shows IQV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.